Results 31 to 40 of about 10,543,784 (217)

Disease-free survival curves for patients with mutations.

, 2016
(A) TP53 and (B) MYD88 genes After applying multiple comparison by using FDR, TP53 and MYD88 showed a tendency for shorter disease-free survival (P = 0.054, both).
JooRyung Huh (3396479), Dong Soon Lee (710952), Sunghoon Huh (3396473), Duhee Bang (736906), Byungjin Hwang (736897), Sungbin Choi (3396470), Si Nae Park (3396488), Kyongok Im (3396467), Jung-Ah Kim (3396485), Hye Yoon Chung (3396482), Eul-Ju Seo (3396476), Je-Hwan Lee (397543)   +11 more
core   +1 more source

Disease-free survival and overall survival of cervical cancer patients after radical hysterectomy and pelvic lymph-node dissection [PDF]

, 2020
Introduction: Radical Hysterectomy and Pelvic Lymph-Node Dissection (RH-PLND), with or without Neoadjuvant Chemotherapy (NAC) nor Adjuvant Therapy (AT), is still the treatment of choice in stages IB-IIB of cervical cancer due to limited access to ...
Ardi Eko Marsanto, -, Brahmana Askandar, -, Primandono Perbowo, -   +2 more
core  

Effects of BMI on prognosis , disease-free survival and overall survival of breast cancer

BMC Cancer
Abstract Background Obese breast cancer patients have worse prognosis than normal weight patients, but the level at which obesity is prognostically unfavorable is unclear. This study aimed to investigate different effects of Body Mass Index (BMI) on prognosis disease-free survival and overall survivor of breast cancer patients.
Vahid Zangouri, Souzan Soufizadeh Balaneji, Roya Golmoradi, Ehsan Kafili, Saleh Bologhi, Seyed Amin Mousavi, Ataollah Ahmadi Hesar, Morteza Amestejani   +7 more
openaire   +3 more sources

Univariate and multivariate survival analysis for disease-free survival.

, 2017
Univariate and multivariate survival analysis for disease-free survival.
Yunbao Pan (286272), Yongchang Wei (3778939), Guoshi Liu (304326), Yufen Yuan (3778936)   +3 more
core   +1 more source

Disease-free survival according to clinical PET type determined by individual surgeons.

, 2017
Disease-free survival according to clinical PET type determined by individual surgeons.
Ho Kyoung Hwang (3164271), Jin Ho Lee (513073), Jae Uk Chong (3779176), Woo Jung Lee (286501), Chang Moo Kang (3164277), Mijin Yun (806359)   +5 more
core   +1 more source

Disease-Free Survival (DFS) of Patients enrolled in the AHWBI trial by Tumor Subtype

, 2017
Disease-Free Survival (DFS) of Patients enrolled in the AHWBI trial by Tumor ...
Ying Wu (19057), Mark Levine (106449), Robin M. Hallett (328197), Anna Dvorkin-Gheva (201099), John Hassell (3529412), Gregory R. Pond (3611303), Tim Whelan (26979), Kay Dias (3529400), Anita L. Bane (3611300)   +8 more
core   +1 more source

LINC00309 is associated with short disease-free survival in breast cancer [PDF]

Cancer Cell International, 2019
Long non-coding RNAs play an important role in breast cancer. Even with adjuvant hormone therapy, patients with estrogen receptor positive breast cancer can present with recurrences and distant metastases. We investigated whether the expression of a novel long non-coding RNA LINC00309 can predict the outcome of breast cancer, especially for hormone ...
Sheng Huang, Yayun Chi, Weiru Chi, Rong Guo, Yonghui Su, Jingyan Xue, Shaoqiang Zhou, Jiankui Wang, Zhuangqing Yang, Jianyun Nie, Zhimin Shao, Dedian Chen, Jiong Wu   +12 more
openaire   +3 more sources

Univariate analysis for disease-free survival and overall survival.

, 2015
Univariate analysis for disease-free survival and overall survival.
Huanwen Wu (697595), Liang Zhu (172992), Huadan Xue (487099), Wenze Wang (586963), Xiaohua Shi (697596), Li Zhang (8200), Hui Zhang (7197), Zhiyong Liang (580570)   +7 more
core   +1 more source

Prognostic Significance of Postoperative and Post-Adjuvant Circulating Tumor DNA in Resected Colon Cancer: A Systematic Review and Meta-Analysis

Journal of Clinical Question
Background: Circulating tumor DNA (ctDNA) is a promising biomarker for detecting minimal residual disease in colon cancer. We performed a systematic review and meta-analysis to assess the prognostic value of postoperative and post-adjuvant chemotherapy ...
En Wang, Maho Sasaki, Daisuke Nagashima, Yushi Fujiwara, Taigo Tokuhara   +4 more
doaj   +1 more source

Disease-Free and Relapse-Free Cancer Survival Analysis with CARESS

, 2017
Survival analysis is used in cancer research to estimate the lifetime of cancer patients. Besides the duration until death, it is interesting to investigate additional events, for example, the reappearance of cancer after successful treatment. To do so, cancer registries use a variety of tools to carry[for full text, please go to the a.m. URL]
Gudenkauf, S, Korfkamp, D, Blohm, K, Kieschke, J   +3 more
openaire   +1 more source